Victory Capital Management Inc. Acquires 1,585,818 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Victory Capital Management Inc. lifted its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 4,432.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,621,593 shares of the company's stock after purchasing an additional 1,585,818 shares during the quarter. Victory Capital Management Inc. owned about 0.95% of Option Care Health worth $50,756,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. UMB Bank n.a. increased its stake in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company's stock valued at $26,000 after acquiring an additional 750 shares during the last quarter. GAMMA Investing LLC increased its stake in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. grew its stake in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock valued at $47,000 after buying an additional 1,446 shares during the last quarter. Blue Trust Inc. grew its stake in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after buying an additional 377 shares during the last quarter. Finally, SageView Advisory Group LLC bought a new position in shares of Option Care Health during the first quarter valued at about $85,000. Institutional investors own 98.05% of the company's stock.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. This trade represents a 69.02 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by insiders.

Option Care Health Stock Performance

NASDAQ:OPCH traded down $0.34 during trading hours on Friday, reaching $21.85. The company had a trading volume of 801,037 shares, compared to its average volume of 1,520,434. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 52 week low of $21.64 and a 52 week high of $34.63. The firm has a market cap of $3.72 billion, a price-to-earnings ratio of 18.65, a PEG ratio of 2.30 and a beta of 1.32. The firm's 50 day moving average price is $28.82 and its 200-day moving average price is $29.44.

Analysts Set New Price Targets

OPCH has been the topic of a number of recent research reports. Jefferies Financial Group cut Option Care Health from a "buy" rating to a "hold" rating and reduced their price objective for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. The Goldman Sachs Group lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Barrington Research dropped their target price on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a report on Thursday, October 31st. JMP Securities increased their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a report on Monday, September 30th. Finally, Bank of America lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $30.83.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.